Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
This report contains market size and forecasts of Meningococcal Polysaccharide Vaccine in global, including the following market information:
Global Meningococcal Polysaccharide Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Meningococcal Polysaccharide Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Meningococcal Polysaccharide Vaccine companies in 2021 (%)
The global Meningococcal Polysaccharide Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polysaccharide Meningtitis AC Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Meningococcal Polysaccharide Vaccine include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology, Chongqing Zhifei Biological, Chengdu Kanghua Biological Products, Changsheng Biotechnology and CanSinoBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meningococcal Polysaccharide Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2021 (%)
Polysaccharide Meningtitis AC
Meningitis ACYW
Global Meningococcal Polysaccharide Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2021 (%)
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Global Meningococcal Polysaccharide Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meningococcal Polysaccharide Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Meningococcal Polysaccharide Vaccine revenues share in global market, 2021 (%)
Key companies Meningococcal Polysaccharide Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Meningococcal Polysaccharide Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO